Recent Company News

• 11:58 AM ET Oct 05, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX +1.6% to 15.56; S&P 500 +0.5% to 7,758.15

• 04:51 PM ET Sep 24, 2026
  

  City Therapeutics, Inc. files for Nasdaq IPO of indeterminate amount - S-1

• 03:31 PM ET Sep 15, 2026
  

  Transcript Intelligence: Silence Therapeutics at H.C. Wainwright Global Investment Conference ($12.56, -0.50)

• 11:59 AM ET Sep 09, 2026
  

  Transcript Intelligence: Silence Therapeutics at Cantor Global Healthcare Conference ($13.49, -0.20)

• 11:59 AM ET Aug 17, 2026
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX +4.9% to 14.95; S&P 500 (0.1%) to 7,775.64

• 08:53 AM ET Aug 12, 2026
  

  StreetAccount Summary - US Initial Syndicate recap for 12-Aug

• 08:18 AM ET Aug 12, 2026
  

  StreetAccount Summary - US Pre-market trading

• 11:23 PM ET Aug 11, 2026
  

  Silence Therapeutics 13.0M-ADS secondary priced at $13.50/ADS ($14.72, 0.00)

• 10:12 PM ET Aug 11, 2026
  

  Silence Therapeutics files to increase size of ADS offering by $40.0M - S-3MEF ($14.72, 0.00)

• 02:29 PM ET Aug 11, 2026
  

  StreetAccount Summary - US equity offerings expected to price for Wednesday, 12-Aug